Found 0 matching trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions. PHASE1 The objective of this study was to evaluate and compare the bioavailability...
Show More Location
Avant Santé Research Center S.A. de C.V.
Learn More & Join Trial
REMAP Trial for Optimizing Surgical Outcomes at UPMC PHASE3 The purpose of this project is to determine the effect of various intervent...
Show More Learn More & Join Trial
Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets PHASE1 An open label, randomized, two-period, two treatment, two-sequence, crossov...
Show More Location
Cliantha Research Limited
Learn More & Join Trial
Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets NA This is a pilot bioequivalence study. It is a randomized, open-label, singl...
Show More Location
Multiple Locations
Learn More & Join Trial
TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy PHASE2 This Phase 2a, randomized, double-blind, active-controlled study will evalu...
Show More Location
UniSC Clinical Trials
Learn More & Join Trial
BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study PHASE1 Objective:
The purpose of this study is to evaluate the effect of food int...
Show More Location
Investigación Farmacológica Y Biofarmaceutica, S.A. de C.V.
Learn More & Join Trial
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period PHASE3 Primary Objective:
To demonstrate the superiority of the insulin glargine/...
Show More Location
Investigational Site Number 8400064
Learn More & Join Trial
Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects PHASE1 The purpose of this trial is to demonstrate bioequivalence of a newly devel...
Show More Location
1288.10.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
GXR RM (Glucophage® Extended Release Reduced Mass) 500 Milligram (mg) Korea Bioequivalence (BE) Study PHASE1 The purpose of this study was to assess bioequivalence (BE) of newly develo...
Show More Location
Clinical Trials Center, Chungnam National University Hospital
Learn More & Join Trial
Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets PHASE1 This trial includes two parts: a food effect (FE) study and a multiple-dose...
Show More Location
Multiple Locations
Learn More & Join Trial